| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
vβ3 Integrin and Fas
Institute of Basic Medical Sciences,1 Departments of Biochemistry,2 Microbiology and Immunology,3 Medical Laboratory Science and Biotechnology,4 Pediatrics, National Cheng Kung University Medical College, Tainan, Taiwan,5 National Applied Research Laboratories, National Laboratory Animal Center, Taipei, Taiwan,6 Institute of Medical Sciences, School of Medicine, Tzu Chi University, Hualien, Taiwan7
Received 21 August 2007/ Returned for modification 4 October 2007/ Accepted 13 January 2008
Our previous work suggested that streptococcal pyrogenic exotoxin (SPE) B-induced apoptosis is mediated through a receptor-like mechanism. In this study, we have identified
vβ3 and Fas as the SPE B receptors for this function. The SPE B fragment without the RGD motif and G308S, a SPE B mutant with the RSD motif, induced less apoptosis than did native SPE B, suggesting that the RGD motif is critical for SPE B-induced apoptosis. Fluorescein isothiocyanate-SPE B binding assays and immunoprecipitation analysis showed that SPE B specifically interacted with
vβ3. Anti-
vβ3 antibody partially inhibited SPE B-induced apoptosis but had no effect on G308S-induced apoptosis. In addition, Fas binding to SPE B was verified in an affinity column and an immunoprecipitation analysis. Anti-Fas antibody inhibited SPE B- and G308S-induced apoptosis in a dose-dependent manner, suggesting that Fas-mediated SPE B-induced apoptosis also occurs RGD independently. Both anti-
vβ3 and anti-Fas antibodies synergistically inhibited SPE B-induced apoptosis. The apoptotic cascades were activated by SPE B and G308S, with a little delay by the latter. After SPE B binding, the cell surface level of
vβ3, but not of Fas, was decreased. The decreased
vβ3 level was restored by treatment with the proteasome inhibitor MG132, suggesting a SPE B-mediated endocytosis of integrin
vβ3 via the ubiquitin-proteasome system. Taken together, our results demonstrate that SPE B-induced apoptosis is mediated through
vβ3 integrin and Fas in a synergistic manner.
Published ahead of print on 28 January 2008.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|